NRP1-dependent autocrine Sema3A signaling was found to promote GBM cell motility through a pathway dependent on Rac1 GTPase activity; in fact, RNA-interference-mediated knockdown of Sema3A in this setting resulted in the inhibition of GBM cell migration and dispersal [30]. The gene discussed is RAC1; the disease is glioblastoma.